Reductive Amination of Aldehydes and Ketones with Primary Amines
NMR (500 MHz, CDCl3) δ: 3.74 (s, 3H, CH3), 3.77 (s,
1H, NH), 4.28 (s, 2H, CH2), 6.60—6.62 (m, 2H, ArH),
6.78—6.79 (m, 2H, ArH), 7.28—7.37 (m, 5H, ArH);
13C NMR (126 MHz, CDCl3) δ: 49.27, 55.83, 114.14,
114.97, 127.17, 127.55, 128.60, 139.75, 142.52, 152.26;
FT-IR (KBr) νmax: 3392, 3060, 3028, 2998, 2906, 2833,
128.57, 129.29, 138.45, 139.45, 148.31; FT-IR (KBr)
νmax: 3418, 3050, 3021, 2919, 2860, 1602, 1505, 1323,
-
+
1
749 cm ; MS (EI) m/z (%): 197 ([M] , 50), 105 (100),
77 (40), 93 (30).
1
N-(4-Methylbenzyl)aniline (Entry 10, Table 2): H
NMR (500 MHz, CDCl3) δ: 2.36 (s, 3H, CH3), 3.96 (s,
1H, NH), 4.30 (s, 2H, CH2), 6.64—6.73 (m, 3H, ArH),
7.17—7.27 (m, 6H, ArH); 13C NMR (126 MHz, CDCl3)
δ: 21.10, 48.11, 112.87, 117.51, 127.53, 129.26, 129.32,
136.41, 136.87, 148.27; FT-IR (KBr) νmax: 3419, 3049,
3020, 2920, 2860, 1603, 1505, 1325, 1266, 806, 748
-
1
1624, 1512, 1245, 1034, 820, 742, 694 cm ; MS (EI):
m/z (%): 212 ([M-H]+, 100), 122 (53), 91 (47), 195
(43), 167 (18).
N-Benzyl-4-chloroaniline (Entry 4, Table 2): 1H
NMR (500 MHz, CDCl3) δ: 4.04 (s, 1H, NH), 4.30 (s,
2H, CH2), 6.54—6.57 (m, 2H, ArH), 7.09—7.10 (m, 2H,
ArH), 7.27—7.34 (m, 5H, ArH); 13C NMR (126 MHz,
CDCl3) δ: 48.36, 113.93, 122.13, 127.37, 127.41,
128.70, 129.07, 138.96, 146.67; FT-IR (KBr) νmax: 3427,
3062, 3028, 2922, 2852, 1600, 1500, 1321, 1177, 815,
-
+
1
cm ; MS (EI) m/z (%): 196 ([M-H] , 85), 105 (100),
77 (18).
1
N-(4-Methoxybenzyl)aniline (Entry 11, Table 2): H
NMR (500 MHz, CDCl3) δ: 3.81 (s, 3H, CH3), 3.93 (s,
1H, NH), 4.26 (s, 2H, CH2), 6.65—6.90 (m, 5H, ArH),
7.19—7.30 (m, 4H, ArH); 13C NMR (126 MHz, CDCl3)
δ: 47.83, 55.31, 112.89, 114.89, 117.53, 128.82, 129.27,
131.49, 148.27, 158.92; FT-IR (KBr) νmax: 3398, 3047,
2962, 2836, 1604, 1514, 1425, 1302, 1253, 1175, 1034,
-
+
1
733, 698 cm ; MS (EI) m/z (%): 216 ([M-H] , 82),
91 (100), 65 (9), 139 (9).
N-Benzyl-4-nitroaniline (Entry 5, Table 2): 1H NMR
(500 MHz, CDCl3) δ: 4.41 (s, 2H, CH2), 4.86 (s, 1H,
NH), 6.54—6.56 (m, 2H, ArH), 7.31—7.35 (m, 5H,
ArH), 8.05—8.07 (m, 2H, ArH); 13C NMR (126 MHz,
CDCl3) δ: 47.70, 111.34, 113.238, 126.37, 127.35,
127.87, 128.96, 137.38, 153.04; FT-IR (KBr) νmax: 3373,
-
+
1
818, 748, 694 cm ; MS (EI) m/z (%): 212 ([M-H] ,
50), 121 (100), 77 (13).
1
N-(4-Chlorobenzyl)aniline (Entry 12, Table 2): H
NMR (500 MHz, CDCl3) δ: 4.02 (s, 1H, NH), 4.30 (s,
2H, CH2), 6.60—6.73 (m, 3H, ArH), 7.17—7.30 (m, 6H,
ArH); 13C NMR (126 MHz, CDCl3) δ: 47.63, 112.91,
117.82, 128.69, 128.75, 129.29, 132.89, 138.00, 147.85;
FT-IR (KBr) νmax: 3419, 3052, 3022, 2923, 2852, 1701,
-
1
2929, 1605, 1519, 740 cm ; MS (EI) m/z (%): 227
([M-H]+, 100), 106 (40), 89 (24), 181 (21), 77 (19).
1
Dibenzylamine (Entry 6, Table 2): H NMR (500
MHz, CDCl3) δ: 1.62 (s, 1H, NH), 3.70—3.80 (m, 4H,
CH2), 7.25—7.33 (m, 10H, ArH); 13C NMR (126 MHz,
CDCl3) δ: 53.18, 58.72, 126.94, 128.15, 128.39, 128.80,
128.97, 129.58, 134.42, 140.35; FT-IR (KBr) νmax: 3308,
-
1
1603, 1088, 1014, 817, 750, 692 cm ; MS (EI) m/z (%):
216 ([M-H]+, 98), 125 (100), 90 (17), 77 (13), 106
(10), 181 (13).
-
1
1
3195, 3062, 3027, 2920, 2837, 1495, 1454 cm ; MS
(EI) m/z (%): 197 ([M]+, 100), 91 (78), 120 (18), 65
(11).
N-Cinnamylaniline (Entry 13, Table 2): H NMR
(500 MHz, CDCl3) δ: 3.83 (s, 1H, NH), 3.95 (s, 2H,
CH2), 6.33—6.36 (m, 1H, CH), 6.70 (d, 3JHH=15.80 Hz,
1H, CH), 6,74—7.76 (m, 3H, ArH), 7.21—7.39 (m, 7H,
ArH); 13C NMR (126 MHz, CDCl3) δ: 46.24, 113.10,
117.60, 126.37, 127.12, 127.56, 128.60, 129.31, 131.56,
136.93, 148.10; FT-IR (KBr) νmax: 3414, 3052, 3023,
N-Benzylpropan-1-amine (Entry 7, Table 2): 1H
NMR (500 MHz, CDCl3) δ: 0.90 (t, 3JHH=7.41 Hz, 3H,
CH3), 1.23 (s, 1H, NH), 1.49—1.53 (m, 2H, CH2), 2.58
3
(t, JHH=7.24 Hz, 2H, CH2), 3.76 (s, 2H, CH2), 7.29—
-
7.31 (m, 5H, ArH); 13C NMR (126 MHz, CDCl3) δ:
11.74, 23.14, 51.32, 54.00, 126.85, 128.10, 128.35,
129.11; FT-IR (KBr) νmax: 3306, 3063, 3028, 2959,
2917, 2834, 1602, 1504, 1322, 966, 748, 692 cm ; MS
(EI) m/z (%): 208 ([M-H]+, 60), 117 (100), 91 (20), 77
(19).
1
-
1
2928, 2873, 2817, 1494, 1454 cm ; MS (EI) m/z (%):
149 ([M]+, 10), 91(100), 106 (5), 120 (60), 65 (15), 77
(5).
N-Cinnamyl-4-methylaniline (Entry 14, Table 2): 1H
NMR (500 MHz, CDCl3) δ: 2.23 (s, 3H, CH3), 3.68 (s,
1H, NH), 3.90 (s, 2H, CH2), 6.32—6.34 (m, 1H, CH),
6.57—6.59 (m, 3H, ArH), 7.00—7.36 (m, 7H, ArH);
13C NMR (126 MHz, CDCl3) δ: 20.36, 46.61, 113.28,
126.32, 126.88, 127.34, 127.46, 128.54, 129.75, 131.42,
136.96, 145.81; FT-IR (KBr) νmax: 3414, 3052, 3023,
1
N-(2-Methylbenzyl)aniline (Entry 8, Table 2): H
NMR (500 MHz, CDCl3) δ: 2.41 (s, 3H, CH3), 3.83 (s,
1H, NH), 4.30 (s, 2H, CH2), 6.67—6.77 (m, 5H, ArH),
7.23—7.37 (m, 4H, ArH); 13C NMR (126 MHz, CDCl3)
δ: 18.96, 46.44, 112.76, 117.51, 126.21, 127.46, 128.30,
129.32, 130.37, 136.37, 137.08, 148.37; FT-IR (KBr)
νmax: 3416, 3050, 3019, 2969, 2919, 2859, 1602, 1505,
-
1
2917, 2834, 1602, 1504, 1322, 966, 748, 692 cm ; MS
(EI) m/z (%): 223 ([M]+, 80), 117 (100), 91 (40), 77
(19).
-
+
1
1332, 747 cm ; MS (EI) m/z (%): 197 ([M] , 50), 105
N-Benzyl-3-phenylprop-2-en-1-amine (Entry 15,
1
(100), 77 (40), 93 (20).
Table 2): H NMR (500 MHz, CDCl3) δ: 1.55 (s, 1H,
1
N-(3-Methylbenzyl)aniline (Entry 9, Table 2): H
NH), 3.44 (s, 2H, CH2), 3.84 (s, 2H, CH2) 6.29—6.34
(m, 1H, CH), 6.53 (d, 3JHH=15.80 Hz, 1H, CH), 7.21—
7.36 (m, 10H, ArH); 13C NMR (126 MHz, CDCl3) δ:
51.22, 53.36, 126.28. 126.98, 127.34, 128.20, 128.44,
128.48, 128.54, 131.41, 137.18, 140.29; FT-IR (KBr)
NMR (500 MHz, CDCl3) δ: 2.38 (s, 3H, CH3), 3.99 (s,
1H, NH), 4.31 (s, 2H, CH2), 6.67—6.75 (m, 3H, ArH),
7.12—7.26 (m, 6H, ArH); 13C NMR (126 MHz, CDCl3)
δ: 21.46, 48.40, 112.89, 117.56, 124.63, 128.03, 128.33,
Chin. J. Chem. 2012, XX, 1—6
© 2012 SIOC, CAS, Shanghai, & WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim
5